https://www.yiliao.com/index.php?action=history&feed=atom&title=HLE-BiTE
HLE-BiTE - 版本历史
2026-04-09T16:21:51Z
本wiki的该页面的版本历史
MediaWiki 1.35.1
https://www.yiliao.com/index.php?title=HLE-BiTE&diff=316159&oldid=prev
103.220.218.6：建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面
2026-02-02T12:31:51Z
<p>建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面</p>
<p><b>新页面</b></p><div><div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff; max-width: 1200px; margin: auto;"><br />
<br />
<div style="margin-bottom: 30px; border-bottom: 1.2px solid #e2e8f0; padding-bottom: 25px;"><br />
<h1 style="color: #0f172a; margin-bottom: 15px; font-size: 1.8em;">HLE-BiTE 技术</h1><br />
<p style="font-size: 1.1em; margin: 10px 0; color: #334155; text-align: justify;"><br />
<strong>HLE-BiTE</strong>（Half-Life Extended Bispecific T-cell Engager），即<strong>半衰期延长型双特异性T细胞衔接器</strong>，是第二代 BiTE 抗体技术。与第一代“经典 BiTE”（如[[倍林妥莫双抗]]）相比，HLE-BiTE 通过融合一个<strong>[[Fc结构域]]</strong>，克服了第一代分子量小、易被肾脏清除的缺点。<br />
<br>• <strong>核心突破：</strong> 将药物在人体内的半衰期从约 2 小时延长至 <strong>5-7 天</strong>以上。<br />
<br>• <strong>临床意义：</strong> 将给药方式从繁琐的“24小时持续静脉泵注”转变为便捷的<strong>“每周或每两周一次”</strong>的短时静脉输注，极大地提高了患者的依从性和生活质量。代表药物为2024年获批的<strong>[[塔尔塔韦]]</strong> (Tarlatamab)。<br />
</p><br />
</div><br />
<br />
<div class="medical-infobox mw-collapsible mw-collapsed" style="width: 100%; max-width: 320px; margin: 0 auto 35px auto; border: 1.2px solid #bae6fd; border-radius: 12px; background-color: #ffffff; box-shadow: 0 8px 20px rgba(0,0,0,0.05); overflow: hidden;"><br />
<br />
<div style="padding: 15px; color: #1e40af; background: linear-gradient(135deg, #e0f2fe 0%, #bae6fd 100%); text-align: center; cursor: pointer;"><br />
<div style="font-size: 1.2em; font-weight: bold; letter-spacing: 1.2px;">HLE-BiTE</div><br />
<div style="font-size: 0.7em; opacity: 0.85; margin-top: 4px; white-space: nowrap;">第二代 BiTE 技术 (点击展开)</div><br />
</div><br />
<br />
<div class="mw-collapsible-content"><br />
<div style="padding: 25px; text-align: center; background-color: #f8fafc;"><br />
<div style="display: inline-block; background: #ffffff; border: 1px solid #e2e8f0; border-radius: 12px; padding: 20px; box-shadow: 0 4px 10px rgba(0,0,0,0.04);"><br />
<div style="width: 140px; height: 90px; background-color: #f1f5f9; display: flex; align-items: center; justify-content: center; color: #94a3b8; font-size: 0.8em; padding: 10px; text-align: center;">[Image: Comparison Diagram: Small Classic BiTE vs Large HLE-BiTE with Fc]</div><br />
</div><br />
<div style="font-size: 0.8em; color: #64748b; margin-top: 12px; font-weight: 600;">结构差异：增加了 Fc 尾巴</div><br />
</div><br />
<br />
<table style="width: 100%; border-spacing: 0; border-collapse: collapse; font-size: 0.85em;"><br />
<tr><br />
<th colspan="2" style="padding: 8px 12px; background-color: #e0f2fe; color: #1e40af; text-align: left; font-size: 0.9em; border-top: 1px solid #bae6fd;">技术参数对比</th><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0; width: 40%;">分子量</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #b91c1c;"><strong>~105 kDa</strong> (vs 54)</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">半衰期 (t1/2)</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #16a34a;"><strong>~210 小时</strong> (vs 2)</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">关键组件</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">[[Fc结构域]] (IgG样)</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">清除途径</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">蛋白分解 (非肾排)</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">给药频率</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #1e40af;">Q1W 或 Q2W</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569;">开发平台</th><br />
<td style="padding: 12px; color: #0f172a;">[[Amgen]] BiTE®</td><br />
</tr><br />
</table><br />
</div><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">核心机制：给药物穿上“防弹衣”</h2><br />
<br />
<div style="background-color: #f0f9ff; border-left: 5px solid #1e40af; padding: 15px 20px; margin: 20px 0; border-radius: 4px;"><br />
<h3 style="margin-top: 0; color: #1e40af; font-size: 1.1em;">为何第一代跑不远？</h3><br />
<p style="margin-bottom: 8px; text-align: justify; font-size: 0.95em; color: #334155;"><br />
<strong>经典 BiTE (Classic)：</strong> 就像一个身材极小的“短跑运动员”（仅由两个 scFv 串联而成）。因为太小（< 60 kDa），它们流经肾脏时会迅速像水一样被<strong>滤网（肾小球）</strong>漏出去。所以必须 24 小时不停地打吊针来补充。<br />
</p><br />
<p style="margin-bottom: 0; text-align: justify; font-size: 0.95em; color: #334155;"><br />
<strong>HLE-BiTE (Next-Gen)：</strong> 给这个运动员背上了一个巨大的<strong>“背包”（Fc 结构域）</strong>。<br />
<br>1. <strong>变大：</strong> 体积超过了肾脏滤网的孔径，不会被漏出去。<br />
<br>2. <strong>循环：</strong> 这个背包里有“通行证”（结合 FcRn 受体）。当药物被细胞吞噬准备分解时，FcRn 会把它“捞”回来并重新释放到血液中（[[FcRn循环]]），从而在体内长时间存活。<br />
</p><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">代际跨越：从 Blincyto 到 Imdelltra</h2><br />
<br />
<div style="overflow-x: auto; margin: 20px auto;"><br />
<table style="width: 100%; border-collapse: collapse; border: 1.2px solid #cbd5e1; font-size: 0.9em; text-align: left;"><br />
<tr style="background-color: #f1f5f9; border-bottom: 2px solid #0f172a;"><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #0f172a; width: 25%;">特性</th><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #475569;">第一代 (Classic)</th><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #1e40af;">第二代 (HLE)</th><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">代表药物</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">[[倍林妥莫双抗]] (Blincyto)</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">[[塔尔塔韦]] (Imdelltra)</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">结构</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">串联 scFv (无 Fc)</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">scFv-Fc 融合蛋白</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">半衰期</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; color: #b91c1c;">~ 2 小时</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; color: #16a34a;"><strong>~ 7 天</strong></td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">给药方式</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;"><strong>连续静脉泵注</strong> (随身泵)</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;"><strong>短时滴注</strong> (门诊化疗)</td><br />
</tr><br />
</table><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">HLE 技术的临床与商业价值</h2><br />
<br />
<ul style="padding-left: 25px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>患者依从性革命：</strong> 不再需要患者佩戴复杂的便携式输液泵回家，消除了导管感染风险和泵故障焦虑，使得 BiTE 疗法可以像普通化疗一样在门诊完成。</li><br />
<li style="margin-bottom: 12px;"><strong>扩大适应症：</strong> 经典 BiTE 主要用于血液瘤（肿瘤负荷低、易接触）；HLE-BiTE 更稳定的血药浓度使其更有潜力攻克<strong>[[实体瘤]]</strong>（如小细胞肺癌、前列腺癌），因为实体瘤需要药物长时间维持有效浓度以渗透组织。</li><br />
</ul><br />
<br />
<div style="font-size: 0.92em; line-height: 1.6; color: #1e293b; margin-top: 50px; border-top: 2.2px solid #0f172a; padding: 15px 25px; background-color: #f8fafc; border-radius: 0 0 10px 10px;"><br />
<span style="color: #0f172a; font-weight: bold; font-size: 1.05em; display: inline-block; margin-bottom: 15px;">学术参考文献 [Academic Review]</span><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[1] <strong>Giffin MJ, et al. (2021).</strong> <em>AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer.</em> <strong>[[Clinical Cancer Research]]</strong>. <br><br />
<span style="color: #475569;">[点评]：详细阐述了 HLE-BiTE 的分子构建策略及其相对于经典 BiTE 在药代动力学（PK）上的巨大优势。</span><br />
</p><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[2] <strong>Suurs FV, et al. (2019).</strong> <em>A review of bispecific T-cell engagers and their potential application in solid tumors.</em> <strong>[[Pharmacology & Therapeutics]]</strong>. <br><br />
<span style="color: #475569;">[点评]：综述了 BiTE 技术的发展历程，重点讨论了半衰期延长技术（如 Fc 融合）是 BiTE 迈向实体瘤治疗的关键一步。</span><br />
</p><br />
</div><br />
<br />
<div style="margin: 40px 0; border: 1px solid #e2e8f0; border-radius: 8px; overflow: hidden; font-family: 'Helvetica Neue', Arial, sans-serif; font-size: 0.9em;"><br />
<div style="background-color: #eff6ff; color: #1e40af; padding: 8px 15px; font-weight: bold; text-align: center; border-bottom: 1px solid #dbeafe;"><br />
HLE-BiTE · 知识图谱<br />
</div><br />
<table style="width: 100%; border-collapse: collapse; background-color: #ffffff;"><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">核心技术</td><br />
<td style="padding: 10px 15px; color: #334155;">[[Fc结构域]] • [[FcRn循环]] • [[肾清除率]]</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">代表药物</td><br />
<td style="padding: 10px 15px; color: #334155;">[[塔尔塔韦]] (AMG 757) • [[Acapatamab]] (AMG 160)</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">前代对比</td><br />
<td style="padding: 10px 15px; color: #334155;">[[倍林妥莫双抗]] (Blinatumomab) • 持续泵注</td><br />
</tr><br />
<tr><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">应用领域</td><br />
<td style="padding: 10px 15px; color: #334155;">[[小细胞肺癌]] • [[前列腺癌]] (PSMA) • [[胶质母细胞瘤]]</td><br />
</tr><br />
</table><br />
</div><br />
<br />
</div></div>
103.220.218.6